BOSTON – Schroder Ventures International Life Sciences Fund II reached a second close on $214 million at the end of April and is expected to wrap at its $250 million cap by the end of June.
The fund was targeted at $200 million and notched a first close on $127 million in December (VCJ, February, page 30).
The vehicle will split its money between early- and late-stage deals and buyouts, targeting companies in the health-care and life sciences sector. Roughly half the fund will be invested in the United States and the remainder mostly in Europe.
Schroder’s first International Life Sciences Fund invested $100 million in more than 30 companies.